Cargando…

Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review

BACKGROUND: Schizophrenia is a highly heterogeneous disorder, and around a third of patients are treatment-resistant. The only evidence-based treatment for these patients is clozapine, an atypical antipsychotic with relatively weak dopamine antagonism. It is plausible that varying degrees of respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillespie, Amy L., Samanaite, Ruta, Mill, Jonathan, Egerton, Alice, MacCabe, James H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237235/ https://www.ncbi.nlm.nih.gov/pubmed/28086761 http://dx.doi.org/10.1186/s12888-016-1177-y

Ejemplares similares

Biological Predictors of Clozapine Response: A Systematic Review
por: Samanaite, Ruta, et al.
Publicado: (2018)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020)

41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)

Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
por: McQueen, Grant, et al.
Publicado: (2021)

Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies
por: Smart, S. E., et al.
Publicado: (2021)

Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
por: Millgate, Edward, et al.
Publicado: (2022)

Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
por: Krajner, Fanni, et al.
Publicado: (2022)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Clozapine and all‐cause mortality in treatment‐resistant schizophrenia: a historical cohort study
por: Cho, J., et al.
Publicado: (2018)

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
por: Millgate, Edward, et al.
Publicado: (2021)

Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2018)

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016)

O3.7. EFFECT OF N-ACETYLCYSTEINE ON BRAIN GLUTAMATE LEVELS AND RESTING PERFUSION IN SCHIZOPHRENIA
por: McQueen, Grant, et al.
Publicado: (2018)

T74. ACADEMIC ACHIEVEMENT AND SCHIZOPHRENIA: A META-ANALYSIS
por: Dickson, Hannah, et al.
Publicado: (2018)

Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia
por: McQueen, Grant, et al.
Publicado: (2019)

Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
por: Millgate, Edward, et al.
Publicado: (2022)

Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
por: Jin, Huajie, et al.
Publicado: (2019)

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
por: Pillinger, Toby, et al.
Publicado: (2019)

Investigating Patient Acceptability of Stratified Medicine for Schizophrenia: A Mixed Methods Study
por: Jilka, Sagar, et al.
Publicado: (2021)

Clozapine Response in Schizophrenia and Hematological Changes
por: Blackman, Graham, et al.
Publicado: (2021)

Sleep and Circadian Rhythm Disturbance in Remitted Schizophrenia and Bipolar Disorder: A Systematic Review and Meta-analysis
por: Meyer, Nicholas, et al.
Publicado: (2020)

A predictor model of treatment resistance in schizophrenia using data from electronic health records
por: Kadra-Scalzo, Giouliana, et al.
Publicado: (2022)

Evaluation of the Cost-effectiveness of Services for Schizophrenia in the UK Across the Entire Care Pathway in a Single Whole-Disease Model
por: Jin, Huajie, et al.
Publicado: (2020)

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
por: Kinon, Bruce J.
Publicado: (2019)

DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
por: Hannon, Eilis, et al.
Publicado: (2021)

Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adults
por: Kępińska, Adrianna P., et al.
Publicado: (2020)

Difference between treatment-resistant schizophrenia and clozapine-resistant schizophrenia
por: Tseng, Ping-Tao, et al.
Publicado: (2022)

Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019)

Efficacy of Facial Exercises in Facial Expression Categorization in Schizophrenia
por: Pancotti, Francesco, et al.
Publicado: (2021)

Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records
por: de Freitas, Daniela Fonseca, et al.
Publicado: (2022)

ECT IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Jagadisha,, et al.
Publicado: (2003)

Pharmacotherapy for treatment-resistant schizophrenia
por: Mcilwain, Meghan E, et al.
Publicado: (2011)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
por: Peitl, Vjekoslav, et al.
Publicado: (2023)

Barriers to using clozapine in treatment-resistant schizophrenia: systematic review
por: Farooq, Saeed, et al.
Publicado: (2019)

Capturing Rest-Activity Profiles in Schizophrenia Using Wearable and Mobile Technologies: Development, Implementation, Feasibility, and Acceptability of a Remote Monitoring Platform
por: Meyer, Nicholas, et al.
Publicado: (2018)

Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb, Nilufar, et al.
Publicado: (2012)

Current perspectives in the treatment of resistant schizophrenia
por: Solanki, R. K., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sgj9rrd5oe237sv6rsn84uodah